| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |